![CAX CAX](https://data.pdbj.org/pdbjplus/data/cc/svg/CAX.svg) | CAX | Name: | (2S,4S)-4-(2,2-DIHYDROXYETHYL)-2,3,3-TRIMETHYLCYCLOPENTANONE | Formula: | C10 H18 O3 | SMILES: | O=C1C(C)C(C)(C)C(CC(O)O)C1 | InChi: | InChI=1S/C10H18O3/c1-6-8(11)4-7(5-9(12)13)10(6,2)3/h6-7,9,12-13H,4-5H2,1-3H3/t6-,7+/m1/s1 | Synonyms: | (2S,4S)-ALPHA-CAMPHOLINIC ACID | Definition date: | 2004-04-22 | Last modified: | 2021-03-13 | Identifier: | (2S,4R)-4-(2,2-dihydroxyethyl)-2,3,3-trimethylcyclopentanone |
|
![ZPN ZPN](https://data.pdbj.org/pdbjplus/data/cc/svg/ZPN.svg) | ZPN | Name: | (2Z,4E)-N-[(S)-[(1S,2E,5S,8E,10Z,17S)-3,11-dimethyl-19-methylidene-7,13-dioxo-6,21-dioxabicyclo[15.3.1]henicosa-2,8,10-trien-5-yl](hydroxy)methyl]hexa-2,4-dienamide | Formula: | C29 H39 N O6 | SMILES: | O=C(/C=CC=CC)NC(O)C1OC(=O)C=CC=C(CC(=O)CCCC2OC(C=C(C)C1)CC(=C)/C2)C | InChi: | InChI=1S/C29H39NO6/c1-5-6-7-13-27(32)30-29(34)26-19-22(4)18-25-17-21(3)16-24(35-25)12-9-11-23(31)15-20(2)10-8-14-28(33)36-26/h5-8,10,13-14,18,24-26,29,34H,3,9,11-12,15-17,19H2,1-2,4H3,(H,30,32)/b6-5+,13-7-,14-8+,20-10-,22-18+/t24-,25-,26-,29-/m0/s1 | Synonyms: | (-)-ZAMPANOLIDE (Bound form) | Definition date: | 2012-12-20 | Last modified: | 2021-03-01 | Release date: | 2013-01-18 | Identifier: | (2Z,4E)-N-[(S)-[(1S,2E,5S,8E,10Z,17S)-3,11-dimethyl-19-methylidene-7,13-dioxo-6,21-dioxabicyclo[15.3.1]henicosa-2,8,10-trien-5-yl](hydroxy)methyl]hexa-2,4-dienamide |
|
![CIE CIE](https://data.pdbj.org/pdbjplus/data/cc/svg/CIE.svg) | CIE | Name: | 2-[[[[(4-CHLORO-6-METHOXY-2-PYRIMIDINYL)AMINO]CARBONYL]AMINO]SULFONYL]BENZOIC ACID ETHYL ESTER | Formula: | C15 H15 Cl N4 O6 S | SMILES: | O=C(Nc1nc(OC)cc(Cl)n1)NS(=O)(=O)c2ccccc2C(=O)OCC | InChi: | InChI=1S/C15H15ClN4O6S/c1-3-26-13(21)9-6-4-5-7-10(9)27(23,24)20-15(22)19-14-17-11(16)8-12(18-14)25-2/h4-8H,3H2,1-2H3,(H2,17,18,19,20,22) | Synonyms: | CHLORIMURON ETHYL | Definition date: | 2002-11-01 | Last modified: | 2021-03-01 | Identifier: | ethyl 2-{[(4-chloro-6-methoxypyrimidin-2-yl)carbamoyl]sulfamoyl}benzoate |
|
![J2A J2A](https://data.pdbj.org/pdbjplus/data/cc/svg/J2A.svg) | J2A | Name: | (2S,5R,7R,8R,10R,12aR,14R,15R,15aS,16R)-7-(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-14-(6-amino-9H-purin-9-yl)-15,16-dihydroxy-2,10-disulfanyloctahydro-2H,10H,12H-5,8-methano-2lambda~5~,10lambda~5~-furo[3,2-l][1,3,6,9,11,2,10]pentaoxadiphosphacyclotetradecine-2,10-dione | Formula: | C20 H24 N10 O11 P2 S2 | SMILES: | C54C(COP(OC1C(O)C(OC1n3c2c(C(N=C(N2)N)=O)nc3)COP(O4)(=O)S)(=O)S)OC(C5O)n6c7c(nc6)c(ncn7)N | InChi: | InChI=1S/C20H24N10O11P2S2/c21-14-8-15(24-3-23-14)29(4-25-8)18-11(32)12-7(39-18)2-37-43(35,45)41-13-10(31)6(1-36-42(34,44)40-12)38-19(13)30-5-26-9-16(30)27-20(22)28-17(9)33/h3-7,10-13,18-19,31-32H,1-2H2,(H,34,44)(H,35,45)(H2,21,23,24)(H3,22,27,28,33)/t6-,7-,10-,11-,12-,13-,18-,19-,42+,43-/m1/s1 | Synonyms: | nonhydrolyzable phosphorothioate analog of 2'3' cyclic GMP-AMP | Definition date: | 2018-08-03 | Last modified: | 2021-03-01 | Release date: | 2019-02-06 | Identifier: | (2S,5R,7R,8R,10R,12aR,14R,15R,15aS,16R)-7-(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-14-(6-amino-9H-purin-9-yl)-15,16-dihydroxy-2,10-disulfanyloctahydro-2H,10H,12H-5,8-methano-2lambda~5~,10lambda~5~-furo[3,2-l][1,3,6,9,11,2,10]pentaoxadiphosphacyclotetradecine-2,10-dione |
|
![EHD EHD](https://data.pdbj.org/pdbjplus/data/cc/svg/EHD.svg) | EHD | Name: | 4-ETHYL-4-HYDROXY-1,12-DIHYDRO-4H-2-OXA-6,12A-DIAZA-DIBENZO[B,H]FLUORENE-3,13-DIONE | Formula: | C20 H16 N2 O4 | SMILES: | O=C1N4C(=CC2=C1COC(=O)C2(O)CC)c3nc5c(cc3C4)cccc5 | InChi: | InChI=1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1H3/t20-/m0/s1 | Synonyms: | CAMPTOTHECIN | Definition date: | 2004-06-09 | Last modified: | 2021-03-01 | Identifier: | (4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione |
|
![0OD 0OD](https://data.pdbj.org/pdbjplus/data/cc/svg/0OD.svg) | 0OD | Name: | trichloro{(1,2,3,4,5-eta)-1,2,3,4-tetramethyl-5-[2-({5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}amino)ethyl]cyclopentadienyl}rhodium(1+) | Formula: | C21 H32 Cl3 N3 O2 Rh S | SMILES: | O=C1NC2C(SCC2N1)CCCCC(=O)NCCc37c4(C)c5(C)c6(C)C3(C)[Rh+]4567(Cl)(Cl)Cl | InChi: | InChI=1S/C21H32N3O2S.3ClH.Rh/c1-12-13(2)15(4)16(14(12)3)9-10-22-19(25)8-6-5-7-18-20-17(11-27-18)23-21(26)24-20 | Synonyms: | [Cp*(Biot-methylene)RhCl(H2O)2]+ | Definition date: | 2012-08-21 | Last modified: | 2021-03-01 | Release date: | 2013-02-08 | Identifier: | trichloro{(1,2,3,4,5-eta)-1,2,3,4-tetramethyl-5-[2-({5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}amino)ethyl]cyclopentadienyl}rhodium(1+) |
|
![LAQ LAQ](https://data.pdbj.org/pdbjplus/data/cc/svg/LAQ.svg) | LAQ | Name: | 5'-O-[(R)-({5-[(3R)-1,2-DITHIOLAN-3-YL]PENTANOYL}OXY)(HYDROXY)PHOSPHORYL]ADENOSINE | Formula: | C18 H26 N5 O8 P S2 | SMILES: | O=P(O)(OCC3OC(n1c2ncnc(N)c2nc1)C(O)C3O)OC(=O)CCCCC4SSCC4 | InChi: | InChI=1S/C18H26N5O8PS2/c19-16-13-17(21-8-20-16)23(9-22-13)18-15(26)14(25)11(30-18)7-29-32(27,28)31-12(24)4-2-1-3-10-5-6-33-34-10/h8-11,14-15,18,25-26H,1-7H2,(H,27,28)(H2,19,20,21)/t10-,11-,14-,15-,18-/m1/s1 | Synonyms: | LIPOYL-AMP | Definition date: | 2006-12-27 | Last modified: | 2021-03-01 | Identifier: | 5'-O-[(R)-({5-[(3R)-1,2-dithiolan-3-yl]pentanoyl}oxy)(hydroxy)phosphoryl]adenosine |
|
![LCL LCL](https://data.pdbj.org/pdbjplus/data/cc/svg/LCL.svg) | LCL | Name: | 2,2-dichloro-N-[(1S,2S)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide | Formula: | C11 H12 Cl2 N2 O5 | SMILES: | O=[N+]([O-])c1ccc(cc1)C(O)C(NC(=O)C(Cl)Cl)CO | InChi: | InChI=1S/C11H12Cl2N2O5/c12-10(13)11(18)14-8(5-16)9(17)6-1-3-7(4-2-6)15(19)20/h1-4,8-10,16-17H,5H2,(H,14,18)/t8-,9-/m0/s1 | Synonyms: | L-Chloramphenicol | Definition date: | 2012-08-16 | Last modified: | 2021-03-01 | Release date: | 2013-05-08 | Identifier: | 2,2-dichloro-N-[(1S,2S)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide |
|
![1WF 1WF](https://data.pdbj.org/pdbjplus/data/cc/svg/1WF.svg) | 1WF | Name: | 4-[(2S)-2-(methylamino)propyl]phenol | Formula: | C10 H15 N O | SMILES: | Oc1ccc(cc1)CC(NC)C | InChi: | InChI=1S/C10H15NO/c1-8(11-2)7-9-3-5-10(12)6-4-9/h3-6,8,11-12H,7H2,1-2H3/t8-/m0/s1 | Synonyms: | 4-Hydroxymethamphetamine | Definition date: | 2013-07-05 | Last modified: | 2021-03-01 | Release date: | 2013-12-11 | Identifier: | 4-[(2S)-2-(methylamino)propyl]phenol |
|
![4AD 4AD](https://data.pdbj.org/pdbjplus/data/cc/svg/4AD.svg) | 4AD | Name: | 4-AMINO-1,4-DIOXOBUTAN-2-AMINIUM ADENOSINE-5'-MONOPHOSPHATE | Formula: | C14 H21 N7 O9 P | SMILES: | O=C(N)CC(C(=O)OP(=O)(O)OCC3OC(n2cnc1c(ncnc12)N)C(O)C3O)[NH3+] | InChi: | InChI=1S/C14H20N7O9P/c15-5(1-7(16)22)14(25)30-31(26,27)28-2-6-9(23)10(24)13(29-6)21-4-20-8-11(17)18-3-19-12(8)21/h3-6,9-10,13,23-24H,1-2,15H2,(H2,16,22)(H,26,27)(H2,17,18,19)/p+1/t5-,6+,9+,10+,13+/m0/s1 | Synonyms: | ASNAMP | Definition date: | 2005-05-20 | Last modified: | 2021-03-01 | Identifier: | 5'-O-[(R)-{[(2S)-4-amino-2-ammonio-4-oxobutanoyl]oxy}(hydroxy)phosphoryl]adenosine |
|
![7CH 7CH](https://data.pdbj.org/pdbjplus/data/cc/svg/7CH.svg) | 7CH | Name: | (2S,4aR,6R,7R,7aS)-6-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide | Formula: | C11 H13 N4 O6 P | SMILES: | O=P3(OCC4OC(n2c1ncnc(N)c1cc2)C(O)C4O3)O | InChi: | InChI=1S/C11H13N4O6P/c12-9-5-1-2-15(10(5)14-4-13-9)11-7(16)8-6(20-11)3-19-22(17,18)21-8/h1-2,4,6-8,11,16H,3H2,(H,17,18)(H2,12,13,14)/t6-,7-,8-,11-/m1/s1 | Synonyms: | 7-CH-cAMP | Definition date: | 2013-12-16 | Last modified: | 2021-03-01 | Release date: | 2014-03-19 | Identifier: | (2S,4aR,6R,7R,7aS)-6-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide |
|
![DL5 DL5](https://data.pdbj.org/pdbjplus/data/cc/svg/DL5.svg) | DL5 | Name: | Spiro(2,4,6-trinitrobenzene[1,2a]-O2',O3'-methylene-adenosine (beta,gamma-methylene)triphosphate | Formula: | C17 H19 N8 O18 P3 | SMILES: | Nc1ncnc2n(cnc12)[CH]3O[CH](CO[P](O)(=O)O[P](O)(=O)C[P](O)(O)=O)[CH]4O[C]5(O[CH]34)C(=C[C](C=C5[N+]([O-])=O)=[N+](O)[O-])[N+]([O-])=O | InChi: | InChI=1S/C17H19N8O18P3/c18-14-11-15(20-4-19-14)22(5-21-11)16-13-12(8(40-16)3-39-46(37,38)43-45(35,36)6-44(32,33)34)41-17(42-13)9(24(28)29)1-7(23(26)27)2-10(17)25(30)31/h1-2,4-5,8,12-13,16H,3,6H2,(H,26,27)(H,35,36)(H,37,38)(H2,18,19,20)(H2,32,33,34)/t8-,12-,13-,16-/m1/s1 | Synonyms: | TNP-AMPPCP | Definition date: | 2015-06-03 | Last modified: | 2021-03-01 | Release date: | 2016-04-13 | Identifier: | (3aR,4R,6R,6aR)-4-(6-aminopurin-9-yl)-3',5'-dinitro-N-oxidanyl-6-[[oxidanyl-[oxidanyl(phosphonomethyl)phosphoryl]oxy-phosphoryl]oxymethyl]spiro[3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxole-2,4'-cyclohexa-2,5-diene]-1'-imine oxide |
|
![SHI SHI](https://data.pdbj.org/pdbjplus/data/cc/svg/SHI.svg) | SHI | Name: | (S)-2-AMINO-3-(3-HYDROXY-ISOXAZOL-4-YL)PROPIONIC ACID | Formula: | C6 H8 N2 O4 | SMILES: | O=C(O)C(N)Cc1conc1O | InChi: | InChI=1S/C6H8N2O4/c7-4(6(10)11)1-3-2-12-8-5(3)9/h2,4H,1,7H2,(H,8,9)(H,10,11)/t4-/m0/s1 | Synonyms: | (S)-DES-ME-AMPA | Definition date: | 2002-09-18 | Last modified: | 2021-03-01 | Identifier: | 3-(3-hydroxyisoxazol-4-yl)-L-alanine |
|
![B40 B40](https://data.pdbj.org/pdbjplus/data/cc/svg/B40.svg) | B40 | Name: | (2S)-N-methyl-1-phenylpropan-2-amine | Formula: | C10 H15 N | SMILES: | N(C(Cc1ccccc1)C)C | InChi: | InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1 | Synonyms: | Methamphetamine | Definition date: | 2009-03-19 | Last modified: | 2021-03-01 | Identifier: | (2S)-N-methyl-1-phenylpropan-2-amine |
|
![BN1 BN1](https://data.pdbj.org/pdbjplus/data/cc/svg/BN1.svg) | BN1 | Name: | (S)-2-AMINO-3-[3-HYDROXY-5-(2-METHYL-2H-TETRAZOL-5-YL)ISOXAZOL-4-YL]PROPIONIC ACID | Formula: | C8 H10 N6 O4 | SMILES: | O=C(O)C(N)Cc1c(onc1O)c2nn(nn2)C | InChi: | InChI=1S/C8H10N6O4/c1-14-11-6(10-13-14)5-3(7(15)12-18-5)2-4(9)8(16)17/h4H,2,9H2,1H3,(H,12,15)(H,16,17) | Synonyms: | 2-ME-TET-AMPA | Definition date: | 2002-07-11 | Last modified: | 2021-03-01 | Identifier: | 3-[3-hydroxy-5-(2-methyl-2H-tetrazol-5-yl)isoxazol-4-yl]alanine |
|
![BTX BTX](https://data.pdbj.org/pdbjplus/data/cc/svg/BTX.svg) | BTX | Name: | ((2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXY-TETRAHYDROFURAN-2-YL)METHYL 5-((3AS,4S,6AR)-2-OXO-HEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL)PENTYL HYDROGEN PHOSPHATE | Formula: | C20 H30 N7 O8 P S | SMILES: | O=C1NC2C(SCC2N1)CCCCCOP(=O)(O)OCC5OC(n3c4ncnc(N)c4nc3)C(O)C5O | InChi: | InChI=1S/C20H30N7O8PS/c21-17-14-18(23-8-22-17)27(9-24-14)19-16(29)15(28)11(35-19)6-34-36(31,32)33-5-3-1-2-4-12-13-10(7-37-12)25-20(30)26-13/h8-13,15-16,19,28-29H,1-7H2,(H,31,32)(H2,21,22,23)(H2,25,26,30)/t10-,11+,12-,13-,15+,16+,19+/m0/s1 | Synonyms: | BIOTINOL-5-AMP | Definition date: | 2005-12-05 | Last modified: | 2021-03-01 | Identifier: | 5'-O-[(R)-hydroxy({5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentyl}oxy)phosphoryl]adenosine |
|
![NWS NWS](https://data.pdbj.org/pdbjplus/data/cc/svg/NWS.svg) | NWS | Name: | Moco-AMP | Formula: | C20 H26 Mo N10 O15 P2 S2 | SMILES: | NC1=NC2=C(N[CH]3[CH](N2)O[CH](CO[P](O)(=O)O[P](O)(=O)OC[CH]4O[CH]([CH](O)[CH]4O)n5cnc6c(N)ncnc56)C7=C3S[Mo](O)(O)(=O)S7)C(=O)N1 | InChi: | InChI=1S/C20H26N10O12P2S2.Mo.2H2O.O/c21-14-8-16(24-3-23-14)30(4-25-8)19-11(32)10(31)5(41-19)1-38-43(34,35)42-44(36,37)39-2-6-12(45)13(46)7-18(40-6)27-15-9(26-7)17(33)29-20(22)28-15 | Definition date: | 2018-12-03 | Last modified: | 2021-02-12 | Release date: | 2021-02-17 | Identifier: | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(1~{R},10~{R},16~{R})-5-azanyl-13,13-bis(oxidanyl)-7,13-bis(oxidanylidene)-17-oxa-12,14-dithia-2,4,6,9-tetraza-13$l^{6}-molybdatetracyclo[8.7.0.0^{3,8}.0^{11,15}]heptadeca-3(8),4,11(15)-trien-16-yl]methyl hydrogen phosphate |
|
![CRA CRA](https://data.pdbj.org/pdbjplus/data/cc/svg/CRA.svg) | CRA | Name: | 1-DEOXY-1-METHOXYCARBAMIDO-BETA-D-GLUCO-2-HEPTULOPYRANOSONAMIDE | Formula: | C9 H16 N2 O8 | SMILES: | O=C(OC)NC1(OC(CO)C(O)C(O)C1O)C(=O)N | InChi: | InChI=1S/C9H16N2O8/c1-18-8(17)11-9(7(10)16)6(15)5(14)4(13)3(2-12)19-9/h3-6,12-15H,2H2,1H3,(H2,10,16)(H,11,17)/t3-,4-,5+,6-,9+/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2020-07-17 | Identifier: | methyl [(2S,3R,4S,5S,6R)-2-carbamoyl-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]carbamate
(non-preferred name) |
|
![ZZ7 ZZ7](https://data.pdbj.org/pdbjplus/data/cc/svg/ZZ7.svg) | ZZ7 | Name: | (2R,4S)-2-[(R)-{[(2R)-2-amino-2-phenylacetyl]amino}(carboxy)methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid | Formula: | C16 H21 N3 O5 S | SMILES: | O=C(NC(C(=O)O)C1SC(C(N1)C(=O)O)(C)C)C(c2ccccc2)N | InChi: | InChI=1S/C16H21N3O5S/c1-16(2)11(15(23)24)19-13(25-16)10(14(21)22)18-12(20)9(17)8-6-4-3-5-7-8/h3-7,9-11,13,19H,17H2,1-2H3,(H,18,20)(H,21,22)(H,23,24)/t9-,10+,11+,13-/m1/s1 | Synonyms: | AMPICILLIN (open form) | Definition date: | 2009-06-11 | Last modified: | 2020-06-17 | Identifier: | (2R,4S)-2-[(R)-{[(2R)-2-amino-2-phenylacetyl]amino}(carboxy)methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid |
|
![J2B J2B](https://data.pdbj.org/pdbjplus/data/cc/svg/J2B.svg) | J2B | Name: | O-[(1R,2R,3R)-5-{[(S)-{[(2R,3R,4R,5R)-2-(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-4-hydroxy-5-(hydroxymethyl)tetrahydro
furan-3-yl]oxy}(sulfanyl)phosphoryl]oxy}-1-(6-amino-9H-purin-9-yl)-1,2-dihydroxypentan-3-yl] dihydrogen (R)-phosphorothioate | Formula: | C20 H28 N10 O12 P2 S2 | SMILES: | C3(C(C(n2c1c(C(N=C(N1)N)=O)nc2)OC3CO)OP(OCCC(C(C(n5c4c(c(ncn4)N)nc5)O)O)OP(=O)(O)S)(=O)S)O | InChi: | InChI=1S/C20H28N10O12P2S2/c21-14-9-15(24-4-23-14)29(5-25-9)18(35)12(33)7(41-43(36,37)45)1-2-39-44(38,46)42-13-11(32)8(3-31)40-19(13)30-6-26-10-16(30)27-20(22)28-17(10)34/h4-8,11-13,18-19,31-33,35H,1-3H2,(H,38,46)(H2,21,23,24)(H2,36,37,45)(H3,22,27,28,34)/t7-,8-,11-,12-,13-,18-,19-,44+/m1/s1 | Synonyms: | cleaved nonhydrolyzable phosphorothioate analog of 2'3' cyclic GMP-AMP | Definition date: | 2018-08-30 | Last modified: | 2020-06-17 | Release date: | 2019-02-06 | Identifier: | O-[(1R,2R,3R)-5-{[(S)-{[(2R,3R,4R,5R)-2-(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-3-yl]oxy}(sulfanyl)phosphoryl]oxy}-1-(6-amino-9H-purin-9-yl)-1,2-dihydroxypentan-3-yl] dihydrogen (R)-phosphorothioate (non-preferred name) |
|
![ME8 ME8](https://data.pdbj.org/pdbjplus/data/cc/svg/ME8.svg) | ME8 | Name: | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]
(2S)-2-azanyl-4-methylsulfanyl-butanoate | Formula: | C15 H23 N6 O8 P S | SMILES: | O=P(OC(=O)C(N)CCSC)(O)OCC3OC(n2cnc1c(ncnc12)N)C(O)C3O | InChi: | InChI=1S/C15H23N6O8PS/c1-31-3-2-7(16)15(24)29-30(25,26)27-4-8-10(22)11(23)14(28-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H,25,26)(H2,17,18,19)/t7-,8+,10+,11+,14+/m0/s1 | Synonyms: | L-methionine-AMP | Definition date: | 2009-10-30 | Last modified: | 2020-06-17 | Identifier: | 5'-O-[(S)-{[(2S)-2-amino-4-(methylsulfanyl)butanoyl]oxy}(hydroxy)phosphoryl]adenosine |
|
![18L 18L](https://data.pdbj.org/pdbjplus/data/cc/svg/18L.svg) | 18L | Name: | (2R)-2-hydroxy-3-(phosphonooxy)propyl (9Z,12Z)-octadeca-9,12-dienoate | Formula: | C21 H39 O7 P | SMILES: | O=P(OCC(O)COC(=O)CCCCCCCC=C/CC=C/CCCCC)(O)O | InChi: | InChI=1S/C21H39O7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(23)27-18-20(22)19-28-29(24,25)26/h6-7,9-10,20,22H,2-5,8,11-19H2,1H3,(H2,24,25,26)/b7-6-,10-9-/t20-/m1/s1 | Synonyms: | D (+)-sn-1-O-linoleoyl-glyceryl-3-phosphate | Definition date: | 2011-01-26 | Last modified: | 2020-06-17 | Identifier: | (2R)-2-hydroxy-3-(phosphonooxy)propyl (9Z,12Z)-octadeca-9,12-dienoate |
|
![478 478](https://data.pdbj.org/pdbjplus/data/cc/svg/478.svg) | 478 | Name: | {3-[(4-AMINO-BENZENESULFONYL)-ISOBUTYL-AMINO]-1-BENZYL-2-HYDROXY-PROPYL}-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL ESTER | Formula: | C25 H35 N3 O6 S | SMILES: | O=C(OC1CCOC1)NC(Cc2ccccc2)C(O)CN(CC(C)C)S(=O)(=O)c3ccc(N)cc3 | InChi: | InChI=1S/C25H35N3O6S/c1-18(2)15-28(35(31,32)22-10-8-20(26)9-11-22)16-24(29)23(14-19-6-4-3-5-7-19)27-25(30)34-21-12-13-33-17-21/h3-11,18,21,23-24,29H,12-17,26H2,1-2H3,(H,27,30)/t21-,23-,24+/m0/s1 | Synonyms: | Amprenavir | Definition date: | 1999-07-08 | Last modified: | 2020-06-17 | Identifier: | (3S)-tetrahydrofuran-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate |
|
![3AM 3AM](https://data.pdbj.org/pdbjplus/data/cc/svg/3AM.svg) | 3AM | Name: | [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate | Formula: | C10 H14 N5 O7 P | SMILES: | O=P(O)(O)OC3C(OC(n2cnc1c(ncnc12)N)C3O)CO | InChi: | InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(17)7(4(1-16)21-10)22-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1 | Synonyms: | 3'-AMP | Definition date: | 2008-01-23 | Last modified: | 2020-06-17 | Identifier: | 3'-adenylic acid |
|
![9AZ 9AZ](https://data.pdbj.org/pdbjplus/data/cc/svg/9AZ.svg) | 9AZ | Name: | (2S)-2-[1-amino-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoic acid | Formula: | C20 H19 N3 O5 | SMILES: | O=C(O)C(O)(C=4C=C3c2nc1cccc(N)c1cc2CN3C(=O)C=4CO)CC | InChi: | InChI=1S/C20H19N3O5/c1-2-20(28,19(26)27)13-7-16-17-10(8-23(16)18(25)12(13)9-24)6-11-14(21)4-3-5-15(11)22-17/h3-7,24,28H,2,8-9,21H2,1H3,(H,26,27)/t20-/m0/s1 | Synonyms: | 9 Amino camptothecin, open form | Definition date: | 2013-07-03 | Last modified: | 2020-06-17 | Release date: | 2013-07-24 | Identifier: | (2S)-2-[1-amino-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoic acid |
|